Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50

Gene Curbs Coffee Urge, Study Finds

By University of Edinburgh | August 26, 2016

Researchers have identified a gene that appears to curb coffee consumption.

People with a DNA variation in a gene called PDSS2 tend to drink fewer cups of coffee, the study found.

Experts say the findings suggest that the gene reduces the ability of cells to breakdown caffeine, causing it to stay in the body for longer.

This means that a person would not need to consume as much coffee to get the same caffeine hit, the team says.

The findings add to previous studies that have identified genes linked to coffee habits and shed new light on the biological mechanisms of caffeine metabolism.

Researchers looked at genetic information from 370 people living in a small village in south Italy and 843 people from six villages in north-east Italy.

Each of the study participants was asked to complete a survey that included a question about how many cups of coffee they drank each day.

The team found that people with the DNA variation in PDSS2 tended to consume fewer cups of coffee than people without the variation. The effect was equivalent to around one fewer cup of coffee per day on average.

The researchers replicated the study in a group of 1731 people from the Netherlands.  The result was similar but the effect of the gene on the number of cups of coffee consumed was slightly lower.

This could be because of the different styles of coffee that are drunk in the two countries, the researchers say.

In Italy, people tend to drink smaller cups such as espresso whereas in the Netherlands the preference is towards larger cups that contain more caffeine overall.

The study was conducted at the Universities of Edinburgh and Trieste, the Burlo Garofolo Pediatric Institute in Italy, the Erasmus Medical Center and PolyOmica, a data analysis company based in Groningen, the Netherlands.

Researchers from the Italian coffee company Illy also participated in the project though the company did not offer financial support. The study is published in the journal Scientific Reports.


Filed Under: Genomics/Proteomics

 

Related Articles Read More >

DNA Script SYNTAX
DNA Script raises $165M Series C for DNA printing platform
DNA Script SYNTAX
DNA Script launches a benchtop DNA printer
DNA
Unraveling the promise of genetics for treating progressive illness 
Alzheimer's disease
How to build a foundation for the next phase of Alzheimer’s disease research

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Drug Discovery news in a minute?

We Deliver!
Drug Discovery & Development Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Drug Discovery and Development
  • MASSDEVICE
  • DEVICETALKS
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • MEDTECH 100
  • Medical Design Sourcing
  • Subscribe to our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50